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The elasmobranch osmoregulatory strategy is predicated on the 
accumulation of nitrogenous compounds, primarily urea and trimethylamine n¬-
oxide (TMAO). Despite the abundance of these plasma osmolytes, it is notable 
that elasmobranchs appear to lack urease and TMA oxidase (Tmase), enzymes 
that scavenge urea-nitrogen and synthesize TMAO, respectively. However, 
urease and Tmase are found in many species of bacteria. Therefore, I 
hypothesized that intestinal bacteria are responsible for urease and Tmase 
activity in elasmobranchs. Absent dietary nitrogen sources, I evaluated the 
effects of reduced intestinal microbiota on osmoregulation in Atlantic stingray 
(Dasyatis sabina) in vivo. D. sabina were given daily broad-spectrum antibiotics 
per os and monitored for weight loss, plasma osmolality, amine metabolites, 
urea, and TMAO. qRT-PCR was used to determine the efficacy of antibiotics at 
reducing the intestinal microbial community and to quantify the hepatic 
expression of carbomoyl phosphate synthetase III (CPS III), the rate-limiting 
enzyme in urea production. Though antibiotics significantly reduced the bacterial 
community in the D. sabina gut, there was no significant change in plasma 
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osmolality, urea, or TMAO. However, amine metabolites changed significantly 
within control and antibiotic groups including benzoic acid, arginine, creatinine 
and L-citrulline. Also observed was significant down-regulation of CPS III 
expression, suggesting that urea production decreased in antibiotic-treated 
individuals. My findings suggest that elasmobranch osmoregulation is robust to 
microbiome perturbation and supports the hypothesis that plasma osmolytes are 
highly conserved in elasmobranchs. This is the first study to test the efficacy and 
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CHAPTER I - INTRODUCTION 
Osmoregulation is a critical physiological process in the aquatic 
environment whereby organisms constantly and intimately interact with water and 
dissolved solutes. Compared to our comprehensive understanding of teleost 
osmoregulatory strategy, a gap exists in our knowledge regarding several critical 
aspects of elasmobranch osmoregulation – primarily the synthesis, maintenance, 
and catabolism of several critical nitrogenous osmolytes. Similar to teleosts, 
elasmobranchs colonize diverse environments with salinities ranging from 
freshwater to hypersaline water (Hamlett 1999; Klimley and Oerdig 2013); 
however, elasmobranchs employ a unique osmoregulatory strategy to cope with 
the complexities of the aquatic environment. While teleosts and elasmobranchs 
both actively excrete Na+ and Cl- (the dominant ions in seawater) via specialized 
chloride cells in the gills, through urinary excretion, and – in the case of 
elasmobranchs – use of the rectal gland, teleosts maintain hypo-osmotic plasma 
with respect to seawater (~360 milliosmoles) whereas elasmobranchs maintain 
plasma of equivalent osmolality to that of seawater (~1000 milliosmoles). 
Elasmobranchs maintain iso-osmotic – or slightly hyper-osmotic plasma – by 
accumulating high levels of nitrogenous compounds such as urea, 
trimethylamine n-oxide (TMAO), amino acids, sarcosine, and betaine (Robertson 
1975; Pang et al. 1977; Yancey and Somero 1979, 1980; Ballantyne et al. 1987; 




Of the total dissolved solutes in elasmobranch plasma, the importance of 
urea and TMAO to elasmobranch osmoregulation cannot be overstated. Urea 
and TMAO comprise roughly 60% of total plasma solutes: 40% and 20%, 
respectively (Goldstein and Funkhouser 1972; Ballantyne and Robinson 2010), 
which is notably more than any other dissolved solute in elasmobranch plasma. 
However, despite the importance of urea and TMAO to elasmobranch 
osmoregulation, our understanding of nitrogenous osmolyte synthesis, 
scavenging, and metabolism in these taxa is limited. 
Urea 
The importance of elasmobranch urea synthesis and retention is dictated 
by the osmotic demands of the aquatic environment. In marine elasmobranchs, 
urea is stored in blood plasma at extraordinarily high concentrations compared to 
other aquatic organisms (300-500mM) (Yancey 1994) and, as previously 
mentioned, constitutes a major proportion of osmolytes: typically, 40% of total 
blood solutes (Ballantyne and Robinson 2010). To a lesser extent, urea is 
synthesized and retained in certain freshwater stenohaline species such as the 
isolated Dasyatis sabina population in St. Johns River, Florida (Johnson and 
Snelson 1996), as well as species of Himantura in southeast Asia (Tam et al. 
2003). Other freshwater stenohaline species such as Potamotrygon spp. 
however, have lost the ability to synthesize urea via the ornithine-urea cycle (O-
UC) and no longer retain urea (Anderson 1991). Interestingly, it has been 
postulated that the ureosmotic strategy of elasmobranchs has contributed to the 
low penetrability of elasmobranchs into freshwater environments (Ballantyne and 
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Robinson 2010). Additionally, urea is energetically costly to produce via the O-
UC (5 ATP per mole of urea) (Anderson 2001), which means urea must be highly 
conserved within tissues. For example, although urea represents 80-97% of 
elasmobranch nitrogenous waste (Anderson 2001; Kajimura et al. 2006), the total 
amount of excreted nitrogenous waste is significantly reduced by retention 
mechanisms in the gills and kidneys (Fines et al. 2001; Morgan et al. 2003; 
Kajimura et al. 2006). This indicates that, rather than constantly manufacturing 
large quantities of urea to account for large losses via excretion or diffusion, a 
majority of urea is retained. 
As with many other aspects of physiology, elasmobranchs employ a 
unique method of urea synthesis. Urea is primarily synthesized via the O-UC 
(Figure 1) in the mitochondria of hepatocytes (Smith 1936; Casey and Anderson 
1985; Perlman and Goldstein 1988; Mommsen and Walsh 1991) though recent 
studies found evidence that the O-UC also occurs in extrahepatic elasmobranch 
tissues such as skeletal muscle and the intestines (Tam et al. 2003; Steele et al. 
2005). Briefly, in most vertebrate taxa, ammonia is converted to carbomoyl 
phosphate, which then enters the O-UC and – through a series of enzymatic 
reactions – is converted to ornithine (which re-enters the cycle) and urea. In this 
process in mammals and amphibians, carbomoyl phosphate synthetase I (CPS I) 
is the first enzyme in the cycle (Meijer et al. 1990; Campbell 1991). Most teleosts 
excrete nitrogen as ammonia thereby negating the necessity of a CPS enzyme 
(Anderson 1991). In contrast, the first enzyme in the elasmobranch O-UC is CPS 
III (Anderson 1991; Anderson 2001). Unlike CPS I, which uses ammonia as a 
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nitrogen-donating substrate, CPS III uses glutamine to synthesize carbomoyl 
phosphate (Perlman and Goldstein 1988; Ballantyne and Robinson 2010). 
Because of this, glutamine must first be synthesized from ammonia by glutamine 
synthetase (GSase), an accessory enzyme located in mitochondria (Casey and 
Anderson 1985). As such, glutamine is the limiting substrate for the O-UC in 
elasmobranchs and CPS III is the rate-limiting step in this cycle. 
The importance of this enzymatic “check-point” is evident when 
considering the method by which urea-nitrogen is scavenged. Urea is hydrolyzed 
via urease to ammonia and carbon dioxide. If ammonia was used as a precursor, 
the catabolism of urea would directly feed back into the O-UC, thus prompting 
further synthesis of urea without additional regulation. Further, if a decrease in 
total urea concentration was advantageous, hydrolysis of urea would likely have 
little effect on urea concentrations; if ammonia was indeed the precursor to urea 
synthesis in elasmobranchs, the end-product of urea break-down would be the 
precursor to urea sythesis. Thus, having an intermediary amine – glutamine – 
and not ammonia as the substrate for CPS III allows urea to be recycled via 
urease hydrolysis.  
Urea-nitrogen recycling would be highly benefial given the nitrogen 
demands of elasmobranch physiology. Elasmobranchs are considered nitrogen-
limited (Wood et al. 2005), thus a method of breaking down urea would allow 
elasmobranchs to re-use urea-nitrogen. It is worth noting that glutamine, which is 
synthesized from ammonia (the product of urea hydrolysis), can also be utilized 
as an oxidative substrate in numerous elasmobranch tissues (Ballantyne 1997). 
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Thus, glutamine produced via urea hydrolysis could be used as an oxidative fuel 
in elasmobranch tissue.  
 A method of recycling urea-nitrogen would also be advantageous given 
the varying osmotic demands of the aquatic environment, particularly for 
euryhaline species that can rapidly alter plasma osmolytes in response to 
environmental conditions. However, it is striking that these taxa appear to lack 
any mechanism for urea catabolism. According to the current literature, urease – 
the enzyme responsible for urea hydrolysis – has not been identified in 
elasmobranchs (Wood 1950; Simidu and Oisi 1951; Knight et al. 1988). Urease 
activity has, however, been identified in species of fungi, plants, invertebrates, 
and – perhaps most notably – bacteria. The existence of urease-positive 
bacterial species is compelling because of microbiological studies of 
elasmobranch tissues, which found multiple species of bacteria inhabiting healthy 
elasmobranch tissues (Grimes et al. 1985; Grimes et al. 1990; Mylniczenko et al. 
2007). For elasmobranch hosts, these endogenous bacteria could confer the 
requisite urease activity that elasmobranchs require but do not inherently 
possess. Indeed, in vitro treatment of the livers of lemon shark (Negaprion 
brevirostris) and tiger shark (Galeocero cuvier) with both antibiotics and 14C-
labeled urea yielded reduced urease activity to the point that it was effectively 
non-existent (Knight et al. 1988). Knight et al. (1988) further concluded that 65% 
of all bacteria taxa isolated from shark tissue using culture-based methods 
(Grimes et al. 1985) are urease-positive, meaning that these bacteria are 
capable of urea hydrolysis, in addition to those species that are able to utilize 
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urea as a sole energy source (e.g. Vibrio damsela and V. charchariae syn. V. 
harveyi) (Grimes et al. 1984). 
The high proportion of urease-positive bacteria in elasmobranch tissues – 
tissues that contain high concentrations of urea – led to the hypothesis that 
bacteria are involved in regulating urea concentrations in elasmobranchs (Knight 
et al. 1988), specifically by hydrolyzing excess urea and recycling urea-nitrogen 
in the form of ammonia. Even without further evidence for the existence of 
bacteria within elasmobranch tissue, the bacterial urease hypothesis could 
certainly extend to the bacteria within the elasmobranch gut. Indeed, a study of 
urea flux within the intestine of spiny dogfish (Squalus acanthias) found an 
inverse relationship between urea and ammonia within the proximal and distal 
regions of the gut, which the authors postulated could be due to bacterial urea 
hydrolysis (Anderson et al. 2009). There is evidence for this kind of vertebrate-
bacteria relationship in other taxa: studies of ruminants found that bacteria in the 
rumen were responsible for much of the urease-driven “nitrogen scavenging” 
during periods of low nitrogen inputs, which is a clear advantage over reliance on 
regular nitrogen input from the diet (Harmeyer and Martens, 1980). Additionally, 
the use of glutamine by CPS III in elasmobranch urea synthesis provides a key 
step in the regulation of this process. As mentioned previously, ammonium must 
first be converted to glutamine in order to re-enter the elasmobranch O-UC. 
Thus, CPS III provides a useful “check-point” for urea synthesis given that 




If endogenous tissue or gut bacteria in elasmobranchs are involved in the 
hydrolysis of urea via urease, such a relationship will represent a novel 
vertebrate-microbe relationship. Even in ruminants, arguably the best example of 
microbial urea-nitrogen scavenging (UNS) with which to compare 
elasmobranchs, this proposed elasmobranch-microbe relationship is 
physiologically unique. Rumen bacteria hydrolyze urea-nitrogen to synthesize 
amino acids and proteins that the host can then reabsorb (Mobley and Hausinger 
1989; Lapierre and Lobley 2001; Stewart and Smith 2005) and thus the 
relationship is predicated on an exchange of dietary nutrients. In contrast, 
elasmobranchs consume a nitrogen-rich diet that allows them to accumulate high 
levels of urea; thus the relationship between elasmobranchs and intestinal 
bacteria is predicated on osmoregulation. Both groups rely on this microbial 
process for nitrogen scavenging; the difference between ruminants and 
elasmobranchs is in how each group utilizes urea and the urea-derived nitrogen 
compounds. Arguably, in elasmobranchs, urea is an even more critical 
compound due to its accumulation as an abundant, important osmolyte. Because 
of the hypothesized importance of bacteria to the osmoregulatory urea cycle in 
elasmobranchs, further study is clearly warranted. 
Trimethylamine n-oxide 
In addition to the complexity of urea cycling, urea is also protein-toxic in 
high concentrations (Yancey et al. 1982; Yancey 1994, 2005). Given the 
exceptionally high urea concentration found in elasmobranch tissues, without 
compensatory mechanisms urea would have deleterious effects on normal 
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protein and enzymatic function. To counteract the effects of urea toxicity, 
methylamines such as TMAO are accumulated in tissues, which allows normal 
protein function and returns enzymatic Km values to pre-urea levels by 
strengthening the structure of water molecules surrounding enzymes and 
indirectly interacting with enzyme functional groups (Yancey and Somero 1979; 
Yancey et al. 1982; Zou et al. 2002; Qu and Bolen 2003). The ratio of urea to 
TMAO is relatively constant: normally between 3:1 and 2:1 in all species of 
elasmobranchs studied to date (Yancey and Somero 1980; Steele et al. 2005). 
Although the presence and importance of TMAO has been well 
established in elasmobranchs (Goldstein and Dewitt-Harley 1973; Strom et al. 
1979; Yancey and Somero 1979, 1980; Yancey 2001; Seibel and Walsh 2002), 
the mechanism by which TMAO is accumulated is still debated. In mammalian 
models, TMAO is synthesized from quaternary ammonium salts such as choline 
and carnitine, which are broken into trimethylamine (TMA) by bacteria in the gut 
(Al-Waiz et al. 1992; Wang et al. 2011; Koeth et al. 2013; Hartiala et al. 2014). 
This microbial-mammalian model appears to be consistent with the breakdown of 
choline to TMA in elasmobranchs (Bilinski 1960; Goldstein and Funkhouser 
1972). TMA is then absorbed from the intestine by colonocytes – cells in the 
intestinal epithelium – and transported to the liver (Wang et al. 2011; Russell et 
al. 2013; Hartiala et al. 2014). In the liver, TMA is oxidized to TMAO by 
trimethylamine oxidase (Tmase) (Beatty 1938; Strom 1980; Seibel and Walsh 
2002), an enzyme that specializes in TMA oxidation (Goldstein and DeWitt-
Harley 1973), or an isoform of flavin-containing monooxygenase (FMO), which 
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oxidizes a broader range of tertiary amines (Ziegler and Mitchell 1972; Schlenk 
1998). FMO isoform 3 (FMO3) is the hepatic isoform that catalyzes the 
monoxygenation of TMA in mammalian models (Lang et al. 1998). Traditionally, 
studies of FMOs have focused on mammalian models, however, recently FMOs 
have been identified in bacteria and several teleosts (Schlenk 1998), most 
notably the euryhaline teleost Oncorhynchus mykiss (Larsen and Schlenck 
2001). In O. mykiss challenged with an increase in salinity, an increase in FMO 
expression was concurrent with TMAO accumulation in muscle tissue (Larsen 
and Schlenk 2001).  
In elasmobranchs, however, there is conflicting and sporadic evidence as 
to the distribution and presence of Tmase or FMO3. Of elasmobranch species 
studied to date, only five species have demonstrated putative Tmase activity: S. 
acanthius (Schlenk and Li-Schlenk 1994), silky shark (Carcharhinus falciformis) 
(Schlenk and Li-Schlenk 1994), grey smooth-hound shark (Mustulus californicus) 
(Baker et al. 1963), nurse shark (Ginglymostoma cirratum (Goldstein and 
Funkhouser 1972; Goldstein and DeWitt-Harley 1973), and lemon shark 
(Negaprion brevirostris) (Goldstein and DeWitt-Harley 1973). Additionally, these 
studies used in vitro and in vivo conversion of 14C-TMA-HCl and choline-methyl-
14C to 14C-TMAO as a proxy for Tmase or FMO3 activity: essentially, production 
of 14C-TMAO indicates a putative Tmase or FMO must exist in elasmobranch 
tissue. However, as all aforementioned studies did not employ antibiotics in vivo 
or in vitro, it would be impossible to elucidate whether the enzyme activity in 
elasmobranchs was of bacterial or elasmobranch origin. Other elasmobranch 
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species either have not been studied or were found to have no detectable levels 
of Tmase (Goldstein and DeWitt-Harley 1973; Seibel and Walsh 2002). 
Due to conflicting evidence for Tmase or FMO in most elasmobranch 
species, it was theorized that TMAO may originate entirely from dietary inputs 
and is therefore accumulated and conserved (Seibel and Walsh 2002; Treberg 
and Dreidzic 2006; Treberg et al. 2006). Fasted S. acanthius maintained nearly 
constant plasma TMAO levels over a 41-day trial (Cohen et al. 1958; Wood et al. 
2010) and fasted winter skate (Leucoraja ocellata) maintained constant plasma 
TMAO over a six-week period (Treberg and Driedzic 2006). During prolonged 
fasting, neither study detected appreciable levels of TMAO production. 
Compounded with low TMAO excretion rates, the authors concluded that TMAO 
must be highly conserved during between-meal periods. While TMAO is likely 
very well-conserved given its importance as an osmolyte, it seems unlikely that 
efficient retention is the only mechanism for regulating TMAO. For example, the 
ability to oxidize TMA has not yet been demonstrated in many species including 
Rajiformes, which includes the family Dasyatidae (Treberg et al. 2006), a finding 
that is particularly surprising given that Dasyatidae includes a number of 
euryhaline species. TMAO has, however, been shown to increase in D. sabina 
(Ferer 2007) and juvenile bull shark (Carcharhinus leucas) (Pillans et al. 2006) 
with increasing salinity even in the absence of dietary inputs. Thus, even though 
no mechanism of TMAO synthesis has been identified among the Dasyatidae 
stingrays, D. sabina can increase plasma TMAO by some currently unidentified 
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mechanism. As suspected by Seibel and Walsh (2006), this suggests that TMAO 
can be synthesized endogenously in elasmobranchs.  
Despite the evidence for endogenous TMAO synthesis, the method of 
synthesis in elasmobranchs is still unknown. Treberg and Driedzic (2006) 
reported evidence of FMO activity but were unable to demonstrate TMA oxidation 
in vivo and in vitro in winter skate (Leucoraja ocellata). Goldstein and 
Funkhouser (1972) demonstrated conversion of 14C-TMA and 14C-choline to 14C-
TMAO in nurse sharks in vivo through a putative Tmase or FMO enzyme. Given 
that conversion of choline to TMA, the precursor to TMAO, is only known to occur 
through microbial oxidation (Marzo and Curti 1997), the authors hypothesized 
that intravenously injected 14C-choline must cross the intestinal lumen; once in 
the gut, microbiota would convert 14C-choline to 14C-TMA, which could then be 
converted by Tmase in the liver to 14C-TMAO. However, because Goldstein and 
Funkhouser (1972) also demonstrated the conversion of 14C-choline to 14C-
TMAO in liver homogenates in vitro, the authors assumed that their initial 
hypothesis regarding bacterial 14C-choline to 14C-TMA was incorrect. Based on 
evidence of symbiont bacteria living in liver tissue (Grimes et al. 1984, 1985; 
Knight et al. 1988), it is possible that bacteria within the liver are able to convert 
choline to TMA similar to bacteria within the gut. Additionally, experimental 
manipulations of choline consumption in mammals indicate that intestinal 
bacteria have a critical threshold for choline and thus are limited in their ability to 
synthesize TMA (Ziesel et al. 1989). In elasmobranchs, additional populations of 
endogenous bacteria within the liver could remediate the overload of choline in 
 
12 
the intestine: another possible benefit of symbiont microbes to the elasmobranch 
host. Given the conflicting evidence for elasmobranch Tmase and FMOs, 
exploring the potential for a bacterial role in TMAO synthesis via TMA oxidation 
within the gut and other elasmobranch tissues is clearly warranted. 
Experimental Design 
Exploring this novel relationship between elasmobranchs and their 
symbiont microbes will elucidate key physiological processes in elasmobranch 
fishes. Because elasmobranchs rely on protein-toxic urea as an osmoregulatory 
compound and, subsequently, TMAO to counteract the effects of urea toxicity, I 
would expect elasmobranchs to possess urease and Tmase. However, 
elasmobranchs do not appear to possess either of these enzymes, which 
indicates the existence of alternative mechanisms for urea and TMAO regulation. 
I hypothesize that intestinal microbes are responsible for the regulation of vital 
osmoregulatory metabolites in elasmobranchs. This would indicate that microbial 
nutrient cycling has profoundly influenced elasmobranch physiology, a finding 
that would substantially change the perception of elasmobranch-microbe 
relationships. 
Establishing gnotobiotic individuals would be an ideal method to study the 
influence of tissue and gut bacteria on elasmobranch physiology; however, 
creation of gnotobiotic elasmobranchs is outside of the scope of this research. 
Gnotobiosis has been established in small mammalian, avian, and amphibian 
model organisms (Baker and Ferguson 1942; Reynier 1959; Gordan 1960) as 
well as a few key species of teleost, namely the zebrafish Danio rerio (Rawls et 
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al. 2004; Bates et al. 2006; Pham et al. 2008). However, the process of creating 
gnotobiotic individuals is time-consuming and expensive, requiring sterile birthing 
and rearing, sterile food and water, and a sterile tank environment (Reynier 
1959) all of which is complicated by the reproductive strategies of elasmobranchs 
and the difficulty of rearing elasmobranchs that are born in captivity. Additionally, 
according to the current literature, there has been no successful generation or 
use of gnotobiosis in an elasmobranch model. For these reasons, gnotobiotic 
elasmobranchs were neither created nor obtained. Therefore, my goal 
throughout these experiments was instead to significantly reduce the 
elasmobranch microbial community using broad-spectrum antibiotics in vivo, an 
accessible alternative to gnotobiosis (Reikvam et al. 2011). Given a significant 
reduction in the intestinal microbiome, I then observed key osmolytes to 
determine if this reduction in microbiota caused an osmoregulatory or 
physiological response. Further, I chose to focus my efforts on reducing the 
intestinal microbiome and not the tissue microbiome; a study of antibiotic efficacy 
has never been published in elasmobranchs, thus delivery of targeted oral 
antibiotics was more likely to succeed at reducing the intestinal microbiome than 
antibiotics injected intravenously or intramuscularly. Additionally, intravenous 
antibiotic injection could cause confounding results given the lack of published 
studies of antibiotic effects on other aspects of elasmobranch physiology. 
This study aims to answer these key hypotheses: (1) intestinal bacteria 
are responsible for the catabolism of urea via urease; and (2) intestinal bacteria 
are responsible for the production of TMAO. In summary, I investigated the 
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potential involvement of endogenous bacteria in the ureosmotic strategy of 
elasmobranch fishes in vivo by significantly reducing the intestinal bacterial 
community and observing subsequent changes in metabolites and mRNA 
expression of a key urea-cycle enzyme, CPS III. If bacteria are responsible for 
TMAO production, I would expect a decrease in TMAO concentrations in 
individuals treated with antibiotics. Additionally, if intestinal microbes are 
responsible for urea hydrolysis, I would expect an increase in urea 
concentrations or an increase in urea excretion, coupled with a decrease in urea 
production (i.e. a decrease in CPS III expression) in antibiotic-treated animals. 
This research will benefit future studies regarding the physiological importance of 
the elasmobranch microbiome and the use of antibiotics in captive 
elasmobranchs.  
Model Organism 
Dasyatis sabina is an ideal elasmobranch model for in vivo study because 
(1) there is a large body of literature on D. sabina physiology, (2) D. sabina are 
both eurythermal and euryhaline and can therefore tolerate a wide range of 
temperatures and salinities, (3) saltwater populations are well-established and 
readily available in the Gulf of Mexico, and (4) my lab is experienced with D. 
sabina husbandry and thus D. sabina are relatively easy to maintain in captivity. 
Given these unique characteristics, D. sabina is an appropriate as well as 
abundant model animal to draw conclusions regarding elasmobranch 





Figure 1. Elasmobranch ornithine-urea cycle. 
The elasmobranch O-UC as depicted in a hepatic mitochondrion. Enzymes are displayed in pink, substrates in black, and 
membrane transport proteins in blue. Enzyme abbreviations are listed as follows: glutamine dehydrogenase (GDHase), 
glutamine synthetase (GSase), carbomoyl phosphate synthetase III (CPS III), ornithine transcarbamoylase (OTCase), 






CHAPTER II – THE OSMOREGULATORY RESPONSE OF ATLANTIC 
STINGRAY, DASYATIS SABINA, TO INTESTINAL MICROBIOME REDUCTION 
Introduction 
Marine elasmobranchs employ a unique osmoregulatory strategy in which 
solutes – primarily nitrogenous compounds – are accumulated in the blood 
plasma and tissues to counteract dehydration due to the osmotic pressure of 
saltwater. The accumulation of nitrogenous compounds such as trimethylamine 
n-oxide (TMAO) and urea (Smith 1936; Pang et al. 1977; Yancey and Somero 
1979; Ballantyne et al. 1987) results in plasma that is iso- or slightly hyper-
osmotic with respect to saltwater. Of the total osmolytes present in elasmobranch 
plasma, urea and TMAO account for roughly 60% of these solutes (Goldstein 
and Funkhouser 1972; Ballantyne and Robinson 2010); thus, the importance of 
these compounds for osmoregulation cannot be overstated. Without constant 
maintenance of high concentrations of urea and TMAO marine elasmobranchs 
will dehydrate, which is detrimental to organismal function and overall health. 
Furthermore, without a method for conserving the nitrogen present in urea or 
synthesizing TMAO elasmobranchs are entirely reliant on dietary sources for 
these critical nitrogenous compounds. This poses a greater challenge for 
euryhaline elasmobranchs such as the Atlantic stingray (Dasyatis sabina), which 
travel freely between freshwater and saline environments and must rapidly alter 




However, despite the importance of these nitrogenous compounds to 
osmoregulation, our understanding of urea and TMAO metabolism in 
elasmobranchs is limited. Given the necessity for elasmobranchs to accumulate 
large quantities of urea and TMAO, nitrogen retention is the most effective and 
energetically efficient way for elasmobranchs to maintain osmolality, particularly 
given that elasmobranchs are nitrogen-limited (Wood et al. 2005). Urease, the 
enzyme responsible for hydrolysis of urea to ammonia, is a key step in urea-
nitrogen scavenging (UNS) and is strikingly absent in elasmobranchs (Wood 
1950; Simidu and Oisi 1951; Knight et al. 1988). Similarly, there is conflicting 
evidence for the presence of an elasmobranch-synthesized trimethylamine 
(TMA) oxidizing enzyme, TMA oxidase (Tmase) or flavin-containing 
monooxygenase 3 (FMO3), which is necessary for the production of TMAO 
(Goldstein and DeWitt-Harley 1973; Seibel and Walsh 2002).  
There is, however, evidence of urease and Tmase activity in multiple 
bacterial taxa. Tmase or bacterial TMA monoxygenase (Tmm) has been 
conclusively found in Methylocella silvestris (Chen et al. 2011) and 
Pseudomonas strain P (Chandler 1983) – a species that was able to use TMA as 
a sole nitrogen source – as well as species of marine and coastal bacteria 
including Ruegeria pomeroyi and Citreicella sp. SE45 (Lidbury et al. 2015), which 
have critical roles in ocean nitrogen cycles through the remineralization of 
nitrogen in the form of ammonia. Additionally, homologous sequences of Tmm 




not only common among bacteria (Mobley and Hausinger 1989), but has been 
identified in bacteria within the elasmobranch microbiome (Grimes et al. 1984, 
1985; Knight et al. 1988; Youngren-Grimes 1990) in addition to the intestinal 
microbiome of other vertebrates (Wozny et al. 1977; Suzuki et al. 1979; 
Robinson et al. 1981). 
Because urease and Tmase or Tmm have yet to been identified in 
elasmobranchs but are readily found in bacteria, I hypothesize that endogenous 
microbes are primarily responsible for urease and TMA oxidation activity. Given 
the importance of urea and TMAO to elasmobranch osmoregulation, if bacteria 
are involved in elasmobranch osmolyte metabolism this will represent a novel 
relationship previously unseen between aquatic vertebrates and microbes. 
Further, this would suggest that elasmobranchs are dependent upon 
endogenous microbes for key osmolyte synthesis and scavenging. 
To test this microbe-osmolyte hypothesis in elasmobranchs, I 
administered a broad-spectrum antibiotic cocktail to captive D. sabina and 
quantified the resulting changes in osmolyte and metabolite concentrations in a 
“bacteria-reduced” state over the course of two weeks. If bacteria were 
responsible for urease activity (i.e. hydrolysis of urea to ammonia), I expected to 
observe a cessation of urease activity and either an increase in plasma urea 
concentration or an increase in expelled urea in antibiotic-treated (+AB) 
individuals. I also explored the effect of bacterial population reduction on the urea 




liver ornithine-urea cycle (O-UC), carbomoyl phosphate synthetase III (CPS III) 
(Casey and Anderson 1985). If reduction in urea recycling indeed caused an 
increase in urea concentration or excretion, I hypothesized that urea production 
would be down-regulated in order to conserve nitrogen in animals with reduced 
intestinal microbiota. Additionally, if bacteria were responsible for TMAO 
production given no dietary input, I expected a cessation of TMA oxidase activity 
and thus a termination of TMAO production in +AB individuals. 
From the literature, in vivo studies of UNS using bacterial knockouts have 
primarily focused on ruminants and their symbiont bacteria (Visek 1978) and this 
topic has never been explored in an elasmobranch model. Additionally, bacteria 
may colonize elasmobranchs tissues and thus the viability of creating a true 
bacterial knockout is complex. This hypothesis is predicated on previous studies 
by Grimes et al. (1984, 1985) and Mylniczenko et al. (2007), who found evidence 
of endogenous bacteria residing in tissues and blood, respectively. Because I 
can more readily guarantee the efficacy of antibiotics on intestinal bacteria, in 
vivo study will focus on the effects of reducing bacteria in the intestines only. The 
effect of intestinal bacterial reduction on TMA oxidation or urease activity in 
elasmobranchs has never been studied in vivo. This experiment seeks to 
determine the relationship between elasmobranchs and gut microbiota in the 
absence of exogenous nitrogen inputs by reducing resident bacteria and 





Materials and Methods 
In Silico Analysis of Urease and Tmase/FMO Nucleotide and Protein Sequences 
Before exploring the possibility of bacterial urease activity in 
elasmobranchs, the absence of an elasmobranch-synthesized urease enzyme 
had to first be verified. Urease protein and nucleotide FASTA sequences (Table 
A1) were aligned using the National Center for Biotechnology Information (NCBI) 
Protein or Nucleotide Basic Local Alignment Search Tool, BLASTp 2.5.0 and 
BLASTn 2.5.0, respectively (https://blast.ncbi.nlm.nih.gov/Blast.cgi) (Altschul et 
al. 1997) and SkateBLAST (http://skatebase.org) (Wang et al. 2012; Wyffels et 
al. 2014). Nucleotide and protein databases were searched for urease 
sequences using the available NCBI taxonomic tree to first identify known 
elasmobranch, chordate, and vertebrate urease sequences. Following this initial 
search, urease sequences were selected from species of bacteria, fungi, and 
plants: the most abundant urease-positive taxa. Using NCBI BLASTp and 
BLASTn, urease protein and nucleotide sequences were aligned to 
elasmobranch sequences (BLAST taxa ID: 7778) using the blastn algorithm for 
“somewhat similar sequences”.  In SkateBLAST, urease sequences were aligned 
to the available Batoidea genome data from the little skate (Leucoraja erinacea); 
transcriptome data from L. erinacae, small-spotted cat shark (Scyliorhinus 
canicula); and the holocephalan elephant shark (Callorhinchus milii); in addition 
to mitochondrial genomes and genes from L. erinacea, the thorny skate 




This same procedure was used to identify an elasmobranch-synthesized 
Tmase enzyme, however, this search was instead directed at FMOs after 
searches for Tmase-specific nucleotide and protein sequences were 
unsuccessful. Instead, nucleotide and protein sequences for FMO – the 
vertebrate hepatic enzyme that monooxygenates compounds including TMA 
(Lang et al. 1998) – were collected from various vertebrates (Table A2) and 
aligned to known elasmobranch sequences using methods identical to those 
used in urease alignments. mRNA sequences were aligned using NCBI tBLASTn 
2.5.0 (https://blast.ncbi.nlm.nih.gov/Blast.cgi) (Altschul et al. 1997). 
Animal Collection and Holding 
D. sabina (n=16) were caught via trawl and hook-and-line in the 
Mississippi Sound by the University of Southern Mississippi (USM) Center for 
Fisheries Research and Development and the USM Marine Education Center, or 
donated by local shrimp fisherman. D. sabina selection was not based on size or 
sex because osmoregulatory strategies should be consistent across both sexes; 
however, only mature individuals were selected because the rigors of the 
experimental methods might negatively affect smaller individuals 
disproportionally. Animals were treated for parasitic copepods for three days in a 
500-gallon tank dosed with 12.5 mL Dimilin (Diflubenzuron N-[{(4- 
Chlorophenyl) amino} carbonyl)-2, 6-difluorobenzamide) prior to transport to the 
Gulf Coast Research Laboratory’s Marine Experimental Research Laboratory 




photoperiod that simulates natural conditions. Holding tanks were maintained at 
20 ppt using Crystal Sea Marinemix® (Marine Enterprises International, 
Baltimore, MD, USA) due to the capture conditions of the experimental D. sabina; 
the salinity in the Mississippi Sound during the sampling period was ≤20 ppt. 
Tank temperature, water quality, and pH were monitored daily to ensure 
uniformity for the duration of the experiment. Water changes occurred in 
response to elevated nutrients and pH. Animals underwent a general health 
assessment and were allowed to acclimate to tank conditions for two weeks prior 
to the start of the experiment. During acclimation, all animals were fed a diet of 
locally caught shrimp twice daily until sated. Any uneaten food was removed from 
the tanks within 15 minutes of feeding. Following the two-week acclimation 
period, animals fasted for the duration of the experiment to control for dietary 
inputs of nitrogen and ensure that all nitrogenous osmolytes were synthesized 
endogenously. 
Experimental Design 
Experiments were carried out in accordance with the USM Animal Care 
and Use Committee (IACUC protocol #15101510). At the MERL, animals were 
divided into one of 18 tanks within three stand-alone recirculating systems 
(Figure 2). Each of these three systems included a head tank, where a bio-filter 
broke down harmful ammonium to nitrate, and six holding tanks. Water was 
pumped from the head tank into each holding tank and then returned to the head 





Figure 2. Animal holding schematic 
Schematic of the in vivo experimental design with antibiotic (+AB) and control tanks randomly distributed among three 




tanks and each tank housed a single animal, each holding tank was treated as a 
singular unit. Male (n=6) and female (n=11) D. sabina were distributed to 
randomly assigned control (n=8) and experimental tanks (n=8). Every 24 hours, 
animals were removed from their holding tanks and placed on a wet cloth on top 
of a flat surface for subsequent weighing, blood draws, and antibiotic (+AB) or 
placebo (control) dosing. Animals were weighed (kg) and blood was drawn from 
each individual prior to the dosing on day one and again on day seven and day 
14. Disc width was also measured on day 14. According to tank assignment, 
animals were dosed with antibiotics or a placebo and then placed back in their 
respective holding tanks. Time spent out of water was limited to two minutes. 
 At a minimum, 0.2 mL of blood was drawn from the dorsal wing using a 
1mL syringe and 22-gauge needle and transferred to a heparinized Vacutainer®+ 
tube. Blood samples were then transferred into a 1.5 mL micro-centrifuge tube 
and centrifuged at 5,000 rpm for 5 minutes to separate plasma from the cellular 
blood components. Plasma supernatant was transferred into a separate tube, 
immediately frozen on dry ice, and stored at -80C until further analysis. 
Immediately following blood draw on day 14, animals were euthanized in 
MS-222 (Tricaine methanesulfonate). Animals were necropsied with autoclave-
sterilized tools, which were cleaned with 95% ethanol between samples. Liver 
samples (≤5 mm section) were collected immediately after sacrifice, flash-frozen 
 





on dry ice, and stored at -80C until further analysis. Whole intestines were 
removed, rapidly divided into three distinct sections (duodenum, spiral valve, and 
colon) using autoclave-sterilized hemostats, and placed in separate sterile Petri 
dishes. The lumen-side of each section was scraped using a laboratory spatula, 
placed into individual 1.5 mL microcentrifuge tubes, and immediately frozen on 
dry ice. Intestinal scrapes were stored at -80C until further analysis. 
Antibiotics 
Because there are no published studies on antibiotic efficacy in 
elasmobranchs, antibiotics were selected in consultation with Dr. Natalie 
Mylniczenko, DVM and recent studies of the intestinal microbiome in mouse 
models (Reikvam et al. 2011; Hill et al. 2010). Our protocol closely follows the 
methods of Reikvam et al. (2011) with the exception of metronadizole, which was 
eliminated because I was unable to achieve complete dissolution in water. 
Additionally, this mixture served as a broad-spectrum antibiotic because each 
chosen antibiotic targeted different bacterial groups: neomycin is an 
aminoglycoside that affects gram-negative bacteria, ampicillin affects gram-
negative and gram-positive bacteria by disrupting the ability of bacteria to 
construct cell walls, and vancomycin affects gram-positive bacteria that are 
unresponsive to ampicillin through a similar mechanism of action. Given that 
species of bacteria from either group synthesize urease or Tmase enzymes, a 
broad-spectrum approach to microbiome reduction was selected to reduce the 




gram-negative or gram-positive bacteria. Control animals received a placebo 
dose containing only autoclave-sterilized de-ionized (DI) water. 
The antibiotic cocktail was made fresh daily and consisted of 100 mg  kg-1 
animal weight Neomycin sulfate (Calbiochem), 100 mg  kg-1 animal weight 
Ampicillin sodium salt (Alfa Aesar), and 50 mg  kg-1 animal weight Vancomycin 
hydrochloride (VWR) dissolved in autoclave-sterilized DI water and administered 
in volumes of 1 mL  kg-1 animal weight. Dosages were administered via oral 
gavage inserted to an area between the gill slits and the stomach to maximize 
antibiotic absorption to the intestine. Separate 14-gauge gavage needles and 3 
mL sterile syringes were used for control and antibiotic groups with care taken to 
remove all air from the syringe prior to administration. Gavage needles were 
thoroughly cleaned with 95% ethanol between doses and stored in 95% ethanol 
when not in use. 
Plasma Osmolality and Osmolytes 
Blood plasma urea (mmol/L), TMAO (mmol/L), and osmolality (mg/kg) 
were measured using samples collected from each individual at day one, seven, 
and 14. Aliquots containing 10 μL of plasma were diluted to 1:25 and urea was 
quantified via colorometric assay (Quantichrom Urea Assay Kit, Biosystems 
Systems). TMAO was quantified spectrophotometrically (Molecular Devices 
SpectraMax M2) with aliquots of 15 μL of plasma following the iron-sulfate 
method (Wekell and Barnett 1991) modified by Raymond (1998) for small plasma 




2003), TMA was not quantified. Osmolality was measured in 10 μL of plasma 
from each sample using a Wescor VAPRO Vapor Pressure Osmometer (Model 
No. 5520). 
Aliquots of 20 μL plasma from a subset of control (n=4) and +AB (n=6) 
individuals at day one and day 14 were sent to the West Coast Metabolomics 
Center (University of California, Davis) for untargeted metabolomic analysis of 
biogenic amines using published techniques for HILIC-ESI QTOF tandem mass-
spectrometry (Feihn et al. 2011). 
DNA Extraction 
DNA was extracted from all frozen gut scrape samples using the DNeasy 
Blood and Tissue kit (Qiagen, Valencia, CA). Following kit instructions for tissue 
DNA extraction, 20 mg of scraped tissue was added to 180 μL of Buffer ATL with 
20 μL proteinase K. Samples were vortexed and incubated at 56ºC for 30 
minutes before proceeding with spin column purification as outlined in the 
manufacturer’s protocol. Extracted DNA was quantified and verified for purity 
spectrophotometrically using a Thermofisher Nanodrop (ND-2000). DNA was 
then frozen at -80C until further analysis. 
RNA Extraction and cDNA Synthesis 
Because urea is primarily synthesized in the liver, hepatic tissue was 
selected as the target tissue for CPS III expression (the rate limiting enzyme in 
the O-UC). RNA was extracted from 25 mg liver tissue per sample, which was 




reagent (Invitrogen Corp., Carlsbad, CA). RNA was then extracted using phenol-
chloroform following the manufacturer’s protocol for RNA isolation. Following 
isolation, 10 μg RNA per sample was purified and concentrated using Zymo 
Clean and Concentrator columns with DNase I treatment (Zymo Research, 
Orange, CA). The sample with the lowest RNA yield was used to determine the 
maximum amount of RNA used for cDNA synthesis, therefore, 0.54 μg purified 
and DNase-treated RNA from each sample was used to synthesize cDNA. Per 
reaction, 0.54μg RNA was combined with 0.5 μg random primers adjusted to a 
final volume of 5 μL. RNA and primers were heated to 70C for 5 minutes, then 
placed on ice until addition of reverse transcription (RT) mix. RT mix consisted of 
4 μL 5X Go Script Reaction Buffer, 4 μL MgCl2, 1 μL PCR nucleotide mix, 0.5 μL 
Recombinant RNasin Ribonucleotide Inhibitor, 1 μL GoScript Reverse 
Transcriptase, and 4.5 μL nuclease-free water per reaction (Promega, Madison, 
WI, cat. no. A5000). For each reaction, 15 μL of RT mix was combined with 5 μL 
of RNA and random primers. RT reactions were carried out as follows: 5 minutes 
annealing at 25C, 60 minutes extension at 42C, followed by reverse 
transcription inactivation at 70C for 15 minutes. Liver cDNA was stored at -20C 
until further analysis. 
qRT-PCR 
Quantitative real-time PCR (qRT-PCR) was performed using PowerUp 
SYBR Green (Applied Biosytems) to determine the efficacy of antibiotics at 




tissue. From each gut scrape DNA or liver cDNA sample, 2 μL of DNA or cDNA 
was added to 18 μL PowerUp SYBR Green master mix (A25742, Applied 
Biosystems), which included 10 μL of PowerUp SYBR Green master mix, 1 μL of 
forward primer at 5 μM, 1 μL of reverse primer at 5 μM, and 6 μL of nuclease-free 
water per reaction. Relative bacterial quantity was assessed in gut scrape DNA 
using a bacterial target gene (16S V2 region) and a host control gene (fish actin) 
(Table A3) following similar protocols in mice (Reikvam et al. 2011). CPS III gene 
expression was assessed in liver cDNA using CPS III primer sequences 
identified by the Evans laboratory (unpublished data) and 18S as a control gene 
(Table A4). Each reaction was run in triplicate to verify reading accuracy on 
MicroAmp Fast Optical 96-well reaction plates (Applied Biosystems) sealed with 
optical adhesive film (VWR). qRT-PCR conditions were performed and analyzed 
using a 7500 Fast Real-Time PCR System (Applied Biosystems) and proceeded 
as follows: an initial denaturation cycle at 50C for 2 minutes and 95C for 2 
minutes, 40 cycles at 95C for 15 seconds and 60C for 1 minute, followed by a 
dissociation curve. 
Statistical Analysis 
After assessment for homogeneity and normality of variance, changes in 
measured osmolytes and animal weight between groups (control and +AB) and 
between time points (day one, seven and 14) were assessed using a two-factor 
repeated-measures analysis of variance (ANOVA). Any analysis yielding a p-




two-sample means was performed on all ANOVA tests for which the null 
hypothesis was rejected.  
 qRT-PCR results for liver tissue CPS III expression and gut microbiome 
reduction were analyzed first with an F-test to determine equality of variance 
between control and antibiotic groups. After verification of variance equality, t-
tests of ∆Ct values (Yuan et al. 2006) were used to determine significant 
expression differences between control and +AB groups. 
Because of the unbalanced number of individuals in control (n=4) and +AB 
(n=6) groups, an ANOVA could not be performed on the metabolomics data. 
Instead, both groups were analyzed separately using paired analyses to detect 
significant differences between plasma metabolites at day one and day 14. 
Variables that were significantly different in the control group were considered to 
be caused by starvation and variables that were significant only in the +AB group 
were considered to be a result of antibiotics and/or a reduction in the host 
microbiome. Using the peak intensity table generated by the West Coast 
Metabolomics Center, metabolites were filtered based on interquartile range to 
eliminate metabolites unlikely to provide significant results. Metabolomics data 
was then normalized by sum to reduce concentration-related differences and 
Pareto-scaled (mean-centered and divided by the square root of the standard 
deviation of each metabolite) to compare all metabolites regardless of absolute 
value. Filtered and normalized values were analyzed using MetaboAnalyst 3.0 




interrogate metabolomics data for significantly different metabolites using t-tests, 
calculate fold-change of metabolites, and generate volcano plots. In this study, I 
used paired tests for all analyses with a fold change threshold of 2.0 and α = 0.05 
representing statistically significance. 
Results 
In Silico Analysis of Urease and FMO Nucleotide and Protein Sequences 
All alignments for urease nucleotide or protein within known elasmobranch 
sequences yielded no meaningful alignment results even with the broadest and 
most forgiving search parameters. All positive hits for elasmobranch nucleotide 
or protein sequences in either database had 0-1% query cover with all aligned 
sequences (Table A1) and were short fragments of <40 base pairs per alignment 
or <20 amino acids. Additionally, all positive hits had <63% identity, which is 
significant given the average full urease sequence length is >5,000 base pairs 
and >500 amino acids. This was true of all urease nucleotide and protein 
sequences interrogated with all available elasmobranch genomes, 
transcriptomes, and mitochondrial genome sequences. 
Search for an elasmobranch-synthesized FMO yielded promising, though 
inconclusive, results. SkateBLAST alignments of the holocephalan C. milii NCBI-
predicted FMO mRNA (NCBI Ref. Seq. XP_007887552.1) with the S. canicula 
transcriptome identified high-identity, low-query cover fragments (<100 bp 
fragments with ≤71% similarity). The predicted FMO protein sequence from C. 




elasmobranch sequences in either NCBI or SkateBASE. To identify the likelihood 
that the NCBI-predicted C. milli FMO sequence is indeed an FMO, C. milii 
sequences were aligned with the sequences of other vertebrate FMOs. C. milli 
FMO mRNA had high-identity, low-query cover alignment with African clawed 
frog (Xenopus laevis) predicted FMO sequence (5% query cover with 75% 
identity). Additionally, the predicted C. milii FMO protein sequence aligned with 
three predicted FMO protein sequences from the West Indian Ocean coelacanth 
(Latimeria chalumnae) (58% identity with 98% query cover), tongue sole 
(Cynoglossus semilaevis) (48% identity with 97% query cover), D. rerio (48% 
identity with 98% query cover) as well as the O. mykiss FMO protein (37% 
identity with 86% query cover). Further, alignment of the O. mykiss FMO 
nucleotide sequence produced high-identity, low-query cover alignments with the 
L. erinacea transcriptome (<100 bp fragments with ≤93% similarity). All broad 
FMO nucleotide and protein queries within the NCBI database returned no 
significant results and positive results were limited to short fragments of <40 base 
pairs or <20 amino acids per alignment. 
Antibiotic Efficacy 
Efficacy of antibiotics was measured based on relative quantification of the 
V2 region of 16S rRNA present in tissue scrapes from three different regions of 
the intestinal tract: duodenum, spiral valve, and colon. Following the methods 
outlined by Yuan et al. (1998), ∆Ct values were compared between +AB and 




rRNA. Fold change was calculated using 2-∆∆Ct values. Using an antibiotic 
cocktail of neomycin, vancomycin, and ampicillin, the total bacterial load in D. 
sabina was significantly reduced in the spiral valve (F-test: p=0.80; t-test 
assuming equal variance: p-value=0.03) (Figure 3) and the colon (F-test: p=0.62; 
t-test assuming equal variance: p-value=0.003) (Figure 3). The bacterial 
community in the duodenum was the only region of the intestine in which 
antibiotics did not significantly reduce the total bacterial load (F-test: p=0.76; t-
test assuming equal variance: p-value=0.15) (Figure 3). 
 
Figure 3. Efficacy of antibiotics in D. sabina intestine 
Note: 16S rRNA (V2 region) mRNA fold changes (control:antibiotic) in D. sabina duodenum, spiral valve, and colon in 
control and +AB animals. Values marked with an asterisk (*) or two asterisks (**) are significantly different from control 










































Animal Weight and Plasma Osmolytes 
Plasma osmolytes did not change significantly over the course of the 
experiment, nor was there a significant difference between D. sabina dosed with 
antibiotics and a placebo. Plasma osmolality (two-factor repeated-measures 
ANOVA, F=0.48, p=0.22) (Figure 4), urea concentration (two-factor repeated-
measures ANOVA, F=0.63, p=0.43) (Figure 5), and TMAO concentration (two-
factor repeated-measures ANOVA, F=0.63, p=0.44) (Figure 6) were not 
significantly altered by antibiotics or the two-week experiment period. However, 
animal weight did significantly change over two weeks (two-factor repeated-
measures ANOVA, F=4.04, p=0.03) (Figure 7). Using a post hoc t-test for paired 
two-sample means, D. sabina weight was significantly different between day one 
and day 14 in both control (p=0.03) and antibiotic (p<0.001) groups. 
Figure 4. Plasma osmolality 
































Figure 5. Plasma urea concentration 
Note: D. sabina blood plasma urea (mM) over two-weeks of in vivo antibiotic or placebo (control) dosage. 
 
Figure 6. Plasma TMAO concentration 











































Figure 7. Animal weight 
Note: D. sabina weight (kg) over two-weeks of in vivo control and +AB animals. 
Metabolomics 
Of the 477 metabolites measured in D. sabina plasma between the 
beginning and end of the two-week in vivo experiment, 32 metabolites 
significantly changed among control D. sabina (paired t-test, p<0.05) (Figure 8) 
(Table 1) and 35 metabolites among antibiotic-treated D. sabina (paired t-test, 
p<0.05) (Figure 9) (Table 2). Within the control group, 27 significantly changed 
metabolites were unique to the control group and 30 were unique to the antibiotic 
group. However, many of these metabolites are unidentified thus no further 
conclusions can be drawn about their importance to overall elasmobranch 
physiology and metabolism at this time; the remainder of this analysis will focus 
on known metabolites. Creatinine and L-citrulline changed significantly in control 































citrulline decreased (t3=-3.72, p=0.03). In the antibiotic group, there was a 
significant increase in 1,2-diamino-2-methylpropane (t5=3.63, p=0.02) and a 
significant decrease in arginine (t5=-2.63, p=0.05). Benzoic acid is another 
metabolite of note, which is the only identified metabolite that significantly 
increased in D. sabina regardless of antibiotic dosage. Further, +AB D. sabina 
experienced a greater increase (4,049-fold change ± 3,163) in benzoic acid than 





Figure 8. Heatmap of significant metabolites in control D. sabina  
Note: D. sabina control (n=4) metabolites that changed significantly (p<0.05) between day one (under the red bar) and 
day 14 (under the green bar). 
Table 1  
Significant metabolites in control D sabina 
Metabolite t stat p value 
1.40_266.18* 8.83 0.003 
2.60_122.07* 8.30 0.004 
1.04_166.09* 7.41 0.005 
8.53_151.05* 7.28 0.005 
4.72_227.12* 6.43 0.008 
8.20_236.14* 5.97 0.009 
7.96_261.14* 5.13 0.014 
8.14_129.07* 4.95 0.016 
9.05_185.13 -4.74 0.018 
7.33_244.11* 4.67 0.019 
9.88_223.99* 4.49 0.021 
8.60_159.15* 4.48 0.021 
9.23_161.13 -4.44 0.021 
9.88_265.02* 4.42 0.021 
9.46_170.09* 4.39 0.022 
8.59_190.12 4.20 0.025 




Table 1 (continued). 
9.39_351.24* 4.18 0.025 
1.42_641.31* 3.93 0.029 
4.53_257.11* 3.78 0.032 
6.88_120.08* 3.76 0.033 
Creatinine MH* 3.76 0.033 
L-Citrulline* -3.72 0.034 
8.52_84.04_8.52_101.07* 3.61 0.036 
8.20_869.23* -3.53 0.039 
9.04_369.25 -3.47 0.040 
6.88_160.10* 3.43 0.042 
8.48_198.12_8.48_220.11* 3.41 0.042 
Benzoic acid, 3-amino- MH 3.34 0.044 
5.08_116.11* 3.23 0.048 
9.50_177.12* 3.21 0.049 
1.44_583.26* 3.21 0.049 
4.75_172.12* 3.21 0.049 
 




Figure 9. Heatmap of significant metabolites in +AB D. sabina  
Heatmap of +AB D. sabina (n=6) blood plasma metabolites that changed significantly (p<0.05) between day one (under 







Table 2  
Significant metabolites in +AB D. sabina 
Metabolite t stat p value 
9.39_523.34* -15.92 1.78E-05 
7.34_215.06* 6.19 0.002 
6.19_537.17* -5.58 0.003 
6.60_137.05* -4.25 0.008 
7.42_241.16* -4.19 0.009 
8.80_203.15* -4.03 0.010 
9.34_771.87* -3.82 0.012 
9.23_161.13 -3.77 0.013 
9.34_772.37* -3.76 0.013 
1.32_151.14* 3.75 0.013 
1,2-Diamino-2-methylpropane MH_noMSMS* 3.63 0.015 
9.39_349.23* -3.62 0.015 
9.39_175.24* -3.50 0.017 
1.45_437.24* 3.47 0.018 
6.96_287.20* -3.47 0.018 
1.64_115.09* 3.43 0.019 
1.43_603.34* 3.39 0.020 
7.97_176.13* -3.38 0.020 




Table 2 (continued). 
1.43_585.32* 3.32 0.021 
6.19_559.15* -3.28 0.022 
8.67_116.03* -3.25 0.023 
Benzoic acid, 3-amino- MH 3.12 0.026 
8.03_356.08* -2.99 0.030 
1.43_311.20* 2.95 0.032 
8.75_159.08_8.75_176.10* -2.88 0.034 
9.73_257.68* 2.85 0.036 
9.14_189.16* -2.78 0.039 
1.45_305.16* 2.77 0.039 
1.43_589.33* 2.76 0.040 
9.04_369.25 -2.64 0.046 
7.84_231.17* -2.64 0.046 
Arginine MH* -2.63 0.047 
9.05_185.13 -2.62 0.047 
9.31_205.15* -2.60 0.048 
8.59_190.12 2.60 0.048 
 
Note: significant metabolites unique to the +AB group are marked with an asterisk (*). 
CPS III Expression in Dasyatis sabina Liver 
Relative expression of CPS III was quantified in liver cDNA using ∆Ct 




results were calculated using 2-∆∆Ct values. Expression of CPS III in the liver was 
significantly reduced in D. sabina dosed with antibiotics (F-test: p=0.28; t-test: 
p=0.02) (Figure 10). 
Figure 10. Liver CPS III expression 
Expression fold change of CPS III mRNA in D. sabina liver tissue in control and +AB animals. Values marked with an 
asterisk (*) are significantly different from control animals (t-test, p<0.05). 
Discussion 
This is the first study to demonstrate an effective method of reducing the 
intestinal microbiome and to subsequently explore the effect of an altered gut 
microbiome on osmoregulation in vivo. Additionally, I provide the first evidence 
that urease and Tmase or an FMO may be absent in elasmobranchs using an in 
silico analysis. This is also, according to current literature, one of only three 
examples of a metabolomic approach to evaluate elasmobranch health and 


































Dove et al. (2012) and a preliminary metabolomic study on the influence of air 
exposure on D. sabina was published by Lambert (2014). Given the efficacy of 
the antibiotics used in this study, if there is a link between the metabolic 
processes of gut bacteria and key osmolytes in elasmobranchs I would expect a 
reduction in the elasmobranch intestinal bacterial assemblage to effect osmolyte 
concentrations. The use of starved D. sabina is particularly compelling because 
in the absence of dietary nitrogen input, all osmolytes must be synthesized, 
maintained, and catabolized endogenously. 
Antibiotic Efficacy 
Using an antibiotic concoction of neomycin, vancomycin, and ampicillin, I 
demonstrated a significant reduction in spiral valve and colon microbiota in +AB 
D. sabina. While I did not observe a significant reduction in the bacterial load in 
the duodenum, the abundance of bacteria in the duodenum is considerably lower 
than that of the distal portion of the intestine (Gorbach 1996; O’Hara and 
Shanahan 2006). Interestingly, the number of bacteria in the duodenum (101 - 
103 viable cells · mL-1) is roughly equivalent to the number of bacteria found in 
the stomach (Gorbach 1996; O’Hara and Shanahan 2006) and is thought to be 
due at least in part to the proximity of the proximal intestine to the highly acidic 
stomach environment. In comparison, the number of bacteria found in the distal 
portions of the gut and the colon is between 1011 - 1012 viable cells · mL-1 




antibiotics effective at reducing the overall microbiome of the elasmobranch 
gastrointestinal tract.  
Though antibiotic-treated animals did lose a significant amount of weight 
over two weeks, they did not proportionally lose more weight than the control 
group. Thus, weight loss is likely solely due to food restriction and not 
compounded by the use of antibiotics. This is an important observation when 
considering the implementation of antibiotics per os in captive elasmobranchs. 
This study is the first published demonstration of antibiotic efficacy in 
elasmobranchs and indicates that this combination, dosage, and method of 
antibiotic delivery could be used in future investigations of microbiome-reduced 
D. sabina. 
Osmolytes and Osmolyte Metabolism 
Before beginning in vivo study, I explored the possibility of an 
elasmobranch-synthesized urease enzyme in silico by aligning urease 
sequences (Table A1) to known elasmobranch genome databases. Despite 
utilizing the broadest search parameters, no significantly homologous nucleotide 
or protein sequence was identified within available elasmobranch genomes. This 
analysis will remain somewhat incomplete until an entire elasmobranch genome 
is published, however, the absence of urease in elasmobranchs is not surprising 
given that a urease enzyme is not found in other vertebrate taxa. Therefore, any 
urease activity in elasmobranchs is unlikely to be the result of an elasmobranch-




elasmobranchs is due to the presence of microbial enzymes. This assumption 
does not come without precedence: in the gut of ruminants, bacteria in the rumen 
recycle urea-nitrogen into ammonia, which can then be used as a nitrogen 
source by other rumen bacteria (Bryant 1959; Mobley and Hausinger 1989; 
Lapierre and Lobley 2011). Additionally, antibiotics have been shown to interrupt 
microbial UNSg in the rumen (Prescott 1953; Muscher et al. 2010).  
Despite a significant reduction in bacterial populations I did not observe a 
significant increase in plasma urea concentrations over time. This could be due 
to a number of compensatory factors, including an increase in urea excretion, a 
decrease in urea production, or a combination of these two factors. I did not 
quantify urea excretion given (1) the complexity of urine dilution in the aquatic 
environment and (2) to avoid trauma caused by catheterization in vivo, however, 
an increase in urea excretion could explain the consistent urea concentrations 
found in antibiotic-treated D. sabina. Due to the high levels of urea found in the 
proximal portion of the elasmobranch gut (Anderson et al. 2009), it is possible 
that – in the absence of urease – urea cannot be converted to ammonia, which 
cannot be transported out of the intestine via ammonia transporter, and is 
excreted as a consequence to maintain steady plasma concentrations. 
Alternatively, expression of urea transporters in the proximal intestine could be 
down-regulated to conserve urea, which may be particularly important in starved 




duodenum, spiral valve, and colon of antibiotic-treated animals would be an 
interesting area of future study.  
It is also possible that urea was not transported to the intestine due to a 
shift in concentration gradient. Studies in ruminants demonstrated a significant 
decrease in urea diffusion into the rumen when the microbial load was reduced, 
indicating that microbial urea metabolism may provide a urea-diffusion 
concentration gradient that is interrupted during antibiotic treatment (Houpt and 
Houpt 1968; Cheng and Wallace 1979). Additionally, during times of low protein 
consumption, ruminant urea excretion via urine decreased disproportionally – an 
84% decrease in urea excretion with only a 57% reduction in protein (Tebot et al. 
2002) – due to increased urea reabsorption in the kidneys (Ergene and Pickering 
1978; Leng et al. 1985). This urea-nitrogen balance between host and microbe 
might also modulate the response of D. sabina to decreased dietary nitrogen 
inputs and possibly the effect of antibiotics: the “critical threshold” of the 
elasmobranch microbiome could be lower than even the significant bacterial 
reduction demonstrated by this study. Thus, D. sabina could have maintained 
homeostatic osmolyte concentrations through compensatory mechanisms by 
both the host and the microbiome.  
This regulation and return to homeostatic conditions by the host is 
supported by the quantification of CPS III mRNA abundance in the liver of control 
and +AB D. sabina. I found that CPS III mRNA was significantly less abundant in 




synthesis by the O-UC, implies a decrease in hepatic urea synthesis. This could 
also be explained by a decrease in UNSg via microbial urease, which caused an 
accumulation of urea-nitrogen in elasmobranch tissue and thus, a reduction in 
requisite urea production. Indeed, in little skate (Raja erinacea) exposed to 
decreased salinity, a decrease in hepatic CPS III activity coincided with an 
increase in urea excretion due to a salinity-driven decrease in required urea 
concentration (Steele et al. 2005). It is also possible that combination of both 
mechanisms (i.e. an increase in urea excretion and a decrease in urea 
production) are involved: urea could initially accumulate leading to an increase in 
urea excretion which could subsequently be counteracted by a decrease in urea 
production.  
The existence of an elasmobranch-synthesized Tmase or FMO was also 
explored using an in silico analysis with the sequences outlined in Table A2. 
FMO has been identified genetically in the euryhaline teleost O. mykiss, 
however, this enzyme has not been identified in elasmobranch taxa using 
modern genetic techniques. Instead, expression of putative FMO has been 
passively identified by precursor conversion to TMAO in vitro (Baker et al. 1963; 
Goldstein and Funkhouser 1972; Goldstein and Dewitt-Harley 1973). As I 
proposed, given the absence of antibiotics in the incubation media in these 
studies, TMA oxidation could be due to bacterial enzymes that are still active in 
vitro and not the result of elasmobranch FMO3 activity. In silico, I found possible 




sequences were relatively short fragments (<100bp), it is certainly possible that 
these fragments are part of an elasmobranch FMO. However, even with 
successful cloning of the elasmobranch FMO gene, further verification would be 
required in order to ensure that this FMO can, in fact, synthesize TMAO: an in-
depth procedure that is outside of the scope of this research. However, these 
findings in silico suggest that existence of an elasmobranch FMO is possible and, 
given that the FMO3 isoform synthesizes TMAO in other vertebrates, could 
indicate endogenous TMAO production in elasmobranchs. The existence of this 
elasmobranch FMO clearly warrants further investigation. 
Similar to urea, TMAO did not change significantly in D. sabina over two 
weeks given antibiotics and lack of food, although – as in the case of urea – 
there are a number of explanations for this finding. Elasmobranchs could be 
robust to perturbations in the microbiome or antibiotics did not significantly 
reduce specific portions of the bacterial assemblage, namely urease- and 
Tmase-positive bacteria (i.e. the proposed “critical threshold” of the 
elasmobranch microbiome). If this “critical threshold” of bacteria is required for 
biologically-appreciable Tmase function, it is possible that I did not sufficiently 
reduce Tmase-positive microbiota in order to see a reduction in enzyme activity. 
Also, given the evidence of bacterial communities endogenous to elasmobranch 
tissues such as liver, kidney, muscle, (Grimes et al. 1984, 1985) and blood 
(Mylniczenko et al. 2007) bacteria within tissues could provide the requisite 




is also possible that +AB individuals had already reached a steady-state of urea 
and TMAO excretion and retention after day seven, in which case I would not 
have observed any significant difference in osmolyte concentrations. It is 
surprising that this steady-state continued for 14 days in starved animals given 
antibiotics, however, Wood et al. (2010) found that fasted S. acanthias 
maintained plasma urea over 56 days at the expense of muscle nitrogen. The 
effects of antibiotics immediately following administration in addition to 
conducting experiments longer than 14 days should be explored in future 
research. Additionally, salinity challenges presented to antibiotic-treated D. 
sabina could be used to test the ability of microbiome-reduced individuals to 
respond to increased salinity (e.g. increased pressure to elevate plasma 
concentrations of both urea and TMAO). 
Metabolites 
From metabolomic analysis, I found a significant increase in benzoic acid 
in both control and +AB animals over the course of two weeks. Benzoic acid is 
found in berries and food preservatives – an unlikely source for elasmobranchs – 
and is produced by phenylalanine and plant polyphenol metabolism in gut 
bacteria. Phenylalanine metabolism seems an unlikely source of benzoic acid 
given the lack of food and the low abundance of phenylalanine (<0.3mM) in 
elasmobranch tissues to date (Ballantyne 1997). An increase in plant 
polyphenols also seems an unlikely source given the absence of dietary inputs, 




oil (Sellami et al. 2014). Degradation of polyphenols and other components of the 
liver during periods of starvation could account for the substantial increase in 
benzoic acid concentration. As an interesting aside, an increase in polyphenol 
intake has been correlated with an improvement in non-alcoholic fatty liver 
disease (Rodriguez-Ramiro et al. 2015). Polyphenols may play an interesting role 
in elasmobranchs given the high abundance of lipids in the liver (Hayashi and 
Kishimura 2000; Sellami et al. 2014). Additionally, an increase in benzoic acid 
could occur due to shifts in gut microbiota community composition toward 
bacteria that are more efficient at degrading polyphenols (Ktsoyan et al. 2011). 
Benzoic acid is also the intermediary to many secondary metabolites, which 
could indicate that metabolic activity is not proceeding efficiently in starved 
animals. Additionally, hippurate formation – the excreted conjugate of benzoic 
acid and glycine – is limited to the availability of glycine, a protein precursor that 
could be limited by starvation conditions and thus limit the excretion of benzoic 
acid. 
 In control animals, creatinine increased and L-citrulline decreased 
significantly. An increase in creatinine could be due to the breakdown of creatine 
in muscles due to starvation, however, this same increase was not seen in 
antibiotic animals that also experience starvation. Among its many functions, L-
citrulline is a substrate in the O-UC that is synthesized from carbomoyl 
phosphate and ornithine. L-citrulline is also associated with intestinal 




nutrient absorption from the intestine and intestinal failure and could also be 
indicative of late-stage renal disease or dysfunction (Crenn et al. 2000) as 
creatinine is cannot be eliminated from the blood. Interestingly, in human 
subjects with endotoxemia – the presence of endotoxins produced from gram-
negative bacteria in the blood – during calorie restriction caused a decrease in 
citrulline (Poeze et al. 2010). This could indicate that control animals are 
immuno-compromised by the in vivo conditions, which is further exacerbated by 
calorie restriction allowing otherwise commensal bacteria to proliferate at the 
detriment of the elasmobranch host. Interestingly, this same decrease was not 
observed in fasted S. acanthias (Wood et al. 2010) even after 56 days, however, 
this could be due to the low concentrations of citrulline present in elasmobranch 
plasma even pre-starvation. 
In D. sabina treated with antibiotics, I observed a significant increase in 
1,2-diamino-2-methylpropane and a decrease in arginine. Though not much 
information is available regarding 1,2-diamino-2-methylpropane, it may be an 
intermediate of amine synthesis. A significant increase could indicate that amine 
synthesis is not proceeding efficiently and to completion. Arginine is a substrate 
in the synthesis of urea and ornithine in the O-UC and is critical for ammonia 
detoxification. Depletion could indicate that arginine was consumed during the 
process of urea generation, however, this contradicts my earlier finding that CPS 
III – the rate limiting O-UC enzyme – is down-regulated. Possibly, prolonged 




in urea production over time, but arginine stores were exhausted by day 14. 
Starvation conditions seem a likely explanation as Wood et al. (2010) found a 
significant decrease in arginine in fasted S. acanthias after five days. Possibly, 
this increase was not observed in control animals due to increased nitrogen loss 
in antibiotic-treated animals. 
Conclusions 
This study provides compelling future directions for microbiome and 
metabolomic studies in elasmobranchs. Given the evidence for UNS in other 
vertebrates and in elasmobranch liver tissue, this is the first study of 
elasmobranch microbial urease activity in vivo and the only exploration of the 
elasmobranch amine metabolome. Despite compelling evidence for microbial 
urea metabolism in other vertebrate taxa and evidence of TMAO synthesis in 
starved elasmobranchs given the conflicting evidence for an elasmobranch-
synthesized Tmase enzyme, the observations of this study suggest that the 
elasmobranch osmoregulatory strategy is robust to perturbations of the 
microbiome. I postulate that this is due to compensatory mechanisms in 
elasmobranch hosts, primarily osmolyte conservation. I also demonstrated 
significant changes in 32 and 36 amine metabolites in control and antibiotic, 
respectively, during starvation conditions and antibiotic treatment. The 
association between bacterial metabolites and elasmobranch osmolytes 




APPENDIX A – Tables 
Table A1.  
Urease sequences queried   
Organism Accession number 
 Nucleotide Protein 
Agaricus bisporus f AJ748112.1 — 
Arthroderma benhamiae f AB304404.1 — 
Bacillus subtilis b Y08559.1 — 
Brucella abortus b — Q2YPD5.1 
Campylobacter pylori b — P69996.1 
Campylobacter sputorum b AB479194.1 — 
Coccidiodes posadasii f U81509.3 — 
Coccidioides immitis f JN001915.1 — 
Corynebacterium glutamicum b — Q79VJ3.1 
Cryptococcus neoformans var. 
grubii f 
AF006062.1 — 
Enterobacter aerogenes b — P18314.1, 
P18316.1 
Escherichia coli (O157:H7) b — Q8XAG0.1 
Fission yeast (Saccharomyces 
pombe) f 
— O00084.1 
Note: Urease nucleotide and protein sequences used for in silico identification of an elasmobranch-synthesized urease. 
Subscripts indicate taxonomic kingdom: bacteria (b), fungi (f), and plant(p). 
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Table A1 (continued). 
Heliobacter heilmannii b L25079.1 — 
Heliobacter pylori b AB018202.1 P14916.2 
Jack bean (Canavalia ensiformis) p M65260.1 P07374.3 
Klebsiella pneumoniae b L07039.1 — 
Mouse-ear cress (Arabidopsis 
thaliana) p 
NM_105422.4 Q9SR52.1 
Mycobacterium tuberculosis b — P9WFF1.1 
Neosartorya fumigate f — Q6A3P9.2 
Pleurotus ostreatus f KF312589.1 — 
Prochlorococcus marinus sub. 
Pastoris b 
— Q9L664.1 
Proteus mirabilis b — P17086.2 
Pseudogymnoascus pannorum f KP195073.1 — 
Pseusogymnoascus destructans f KP195072.1 — 
Rhizoctonia solani f CAOJ01012310.1 — 
Rice (Oryza sativa sub. Indica) p — E0ZS48.1 
Solanum tuberosum p AJ308543.1, 
AJ308544.1 
— 
Sporosarcina pasteurii b — P41020.1 
Staphylococcus saprophyticus b — Q4A0J5.3 
Note: Urease nucleotide and protein sequences used for in silico identification of an elasmobranch-synthesized urease. 




Table A1 (continued). 
Streptococcus salivarius b — P50047.3 
Uncultured rumen bacterium clone 
SU134 b 
JQ612071.1 — 
Uncultured rumen bacterium clone 
SU75 b 
JQ612049.1 — 
Ureaplasma urealyticum b L40490.1 — 
Vibrio parahaemolyticus b D86348.1 — 
Yersinia enterocolitica b L24101.1 P31494.3 
 
Note: Urease nucleotide and protein sequences used for in silico identification of an elasmobranch-synthesized urease. 
Subscripts indicate taxonomic kingdom: bacteria (b), fungi (f), and plant(p). 
Table A2.  
FMO sequences queried 
Organism Accession number 
 Nucleotide/mRNA Protein 
Xenopus laevis* XM_018253772.1 — 
Xenopus tropicalis  — AAH91044.1 
Oncorhynchus mykiss  EU519462.1 ACC95536.1 
Gallu gallus  AH012591.2p NP_989910.1 
Sus scrofa  DQ532373.1 p — 
Callorhinchus milii* XM_007889361.1 XP_007887552.1 
Note: FMO nucleotide and protein sequences used for in silico identification of an elasmobranch-synthesized FMO. Taxa 





Note: FMO nucleotide and protein sequences used for in silico identification of an elasmobranch-synthesized FMO. Taxa 
marked with an asterisk (*) are NCBI predicted FMO sequences. Accession numbers marked ‘p’ indicates partial FMO 
sequences. 
Table A3.  
Antibiotic efficacy qRT-PCR primer sequences 
Gene Primer Primer sequence 
16S rRNA V2 region Forward 5’-AGYGGCGIACGGGTGAGTAA-3’ 
16S rRNA V2 region Reverse 5’-CYIACTGCTGCCTCCCGTAG-3’ 
Fish actin Forward 5’-TCGTCATGGACTCTGGTGATGG-3’ 
Fish actin Reverse 5’-CTCCTGCTCAAAGTCCAGTGC-3’ 
 
Note: qRT-PCR primers for 16S quantification of bacteria in D. sabina gut scrapes from control and antibiotic-dosed 





Table A2 (continued). 
Latimeria chalumnae* — XP_014352628.1 
Danio rerio* — XP_001332968.4 
Cynoglossus semilaevis* — XP_008331640.1 
Homo sapiens  AH006707.2 — 
Mus musculus — BAA03745.1 
Pan troglodytes  AH012919.2 — 
Bos Taurus AF488421.1p AAI02684.1 
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Table A4.  
Liver CPS III qRT-PCR primer sequences  
Gene Primer Primer sequence 
CPS III Forward 5’-ATATCCTGTGGCCTTTGACG-3’ 
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